CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The new online Learning Center with new content can still be found under the “Training” folder on ...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
We are very excited to launch our new website! Please take a few moments to click around and explore...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...